Crossmark

Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children

Crossref DOI link: https://doi.org/10.1186/s12934-020-01319-y

Published Online: 2020-03-06

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gallardo-Becerra, Luigui

Cornejo-Granados, Fernanda

García-López, Rodrigo

Valdez-Lara, Alejandra

Bikel, Shirley

Canizales-Quinteros, Samuel

López-Contreras, Blanca E.

Mendoza-Vargas, Alfredo

Nielsen, Henrik

Ochoa-Leyva, Adrián https://orcid.org/0000-0002-4701-2303
Funding

Funding for this research was provided by:

CONACyT (SALUD-2014-C01-234188)

CONACYT (CB-2013-223279)

PAPIIT (IA203118, IN215520)
License Information

Text and Data Mining valid from 2020-03-06

Version of Record valid from 2020-03-06
More Information

Article History

Received: 23 December 2019

Accepted: 26 February 2020

First Online: 6 March 2020

Ethics approval and consent to participate

: The Ethic Committee of the National Institute of Genomic Medicine (INMEGEN) in Mexico City approved the study. The parents or guardians of donors signed the informed consent form for participation, and the donors assented to participate.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below